<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Infection and Immunity</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Infection and Immunity</journal-title><trans-title-group xml:lang="ru"><trans-title>Инфекция и иммунитет</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2220-7619</issn><issn publication-format="electronic">2313-7398</issn><publisher><publisher-name xml:lang="en">SPb RAACI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">828</article-id><article-id pub-id-type="doi">10.15789/2220-7619-2018-4-452-464</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>MOLECULAR BASES OF EPIDEMIOLOGY, DIAGNOSTICS, PREVENTION AND TREATMENT OF INFECTIOUS DISEASES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>МОЛЕКУЛЯРНЫЕ ОСНОВЫ ЭПИДЕМИОЛОГИИ, ДИАГНОСТИКИ, ПРОФИЛАКТИКИ И ЛЕЧЕНИЯ АКТУАЛЬНЫХ ИНФЕКЦИЙ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">CURRENT POSSIBILITIES AND POTENTIAL DEVELOPMENT OF MOLECULAR ENTEROVIRUS SURVEILLANCE. EXPERIENCE OF RUSSIAN FEDERATION</article-title><trans-title-group xml:lang="ru"><trans-title>СОВРЕМЕННЫЕ ВОЗМОЖНОСТИ И НАПРАВЛЕНИЯ РАЗВИТИЯ МОЛЕКУЛЯРНОЭПИДЕМИОЛОГИЧЕСКОГО МОНИТОРИНГА В НАДЗОРЕ ЗА ЭНТЕРОВИРУСНЫМИ ИНФЕКЦИЯМИ. ОПЫТ РОССИЙСКОЙ ФЕДЕРАЦИИ</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Lukashev</surname><given-names>A. N.</given-names></name><name xml:lang="ru"><surname>Лукашев</surname><given-names>А. Н.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD, MD (Medicine), Professor, Director</p><p>119435, Malaya Pirogovskaya str., 20/1,Phone: +7 (499) 246-80-49 </p></bio><bio xml:lang="ru"><p>д.м.н., профессор РАН, директор </p><p>119435, Россия, Москва, ул. Малая Пироговская, 20/1, Институт медицинской паразитологии, тропических и трансмиссивных заболеваний им. Е.И. Марциновского.</p><p>Тел.: 8 (499) 246-80-49</p></bio><email>alexander_lukashev@hotmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Golitsina</surname><given-names>L. N.</given-names></name><name xml:lang="ru"><surname>Голицына</surname><given-names>Л. Н.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD (Biology), Leading Researcher, Laboratory of Molecular Epidemiology of Viral Infections</p></bio><bio xml:lang="ru"><p>к.б.н., ведущий научный сотрудник лаборатории молекулярной эпидемиологии вирусных инфекций</p></bio><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Vakulenko</surname><given-names>Y. A.</given-names></name><name xml:lang="ru"><surname>Вакуленко</surname><given-names>Ю. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Junior Researcher, Research Department</p></bio><bio xml:lang="ru"><p>младший научный сотрудник научноисследовательского отдела</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Akhmadishina</surname><given-names>L. V.</given-names></name><name xml:lang="ru"><surname>Ахмадишина</surname><given-names>Л. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD (Medicine), Head of the Clinical Diagnostic Laboratory</p></bio><bio xml:lang="ru"><p>к.м.н., зав. лабораторией клиникодиагностической лабораторией</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Romanenkova</surname><given-names>N. I.</given-names></name><name xml:lang="ru"><surname>Романенкова</surname><given-names>Н. И.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD (Medicine), Leading Researcher, Laboratory of Etiology and Control of Viral Infections</p></bio><bio xml:lang="ru"><p>к.м.н., ведущий научный сотрудник лаборатории этиологии и контроля вирусных инфекций</p></bio><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Sapega</surname><given-names>E. Yu.</given-names></name><name xml:lang="ru"><surname>Сапега</surname><given-names>Е. Ю.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD (Medicine), Head of Enterovirus Surveillance Center</p></bio><bio xml:lang="ru"><p>к.м.н., руководитель центра центра по надзору за энтеровирусами</p></bio><xref ref-type="aff" rid="aff4"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Morozova</surname><given-names>N. S.</given-names></name><name xml:lang="ru"><surname>Морозова</surname><given-names>Н. С.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Head of Epidemiological Surveillance Department</p></bio><bio xml:lang="ru"><p>зав. отделом обеспечения эпидемиологического надзора</p></bio><xref ref-type="aff" rid="aff5"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Novikova</surname><given-names>N. A.</given-names></name><name xml:lang="ru"><surname>Новикова</surname><given-names>Н. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD (Biology), Professor</p></bio><bio xml:lang="ru"><p>д.б.н., профессор, зав. лабораторией молекулярной эпидемиологии вирусных инфекций</p></bio><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Trotsenko</surname><given-names>O. E.</given-names></name><name xml:lang="ru"><surname>Троценко</surname><given-names>О. Е.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD, MD (Medicine), Professor, Director</p></bio><bio xml:lang="ru"><p>д.м.н., профессор, директор</p></bio><xref ref-type="aff" rid="aff4"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Ivanova</surname><given-names>O. E.</given-names></name><name xml:lang="ru"><surname>Иванова</surname><given-names>О. Е.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD, MD (Medicine), Professor, Head of Poliomyelitis and Other Enterovirus Infections</p></bio><bio xml:lang="ru"><p>д.м.н., профессор, руководитель отдела полиомиелита и других энтеровирусных инфекций</p></bio><xref ref-type="aff" rid="aff6"/><xref ref-type="aff" rid="aff7"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Martsinovsky Institute of Medical Parasitology, Tropical and Vector-Borne Diseases, Sechenov First Moscow State Medical University, Moscow</institution></aff><aff><institution xml:lang="ru">Институт медицинской паразитологии, тропических и трансмиссивных заболеваний им. Е.И. Марциновского, ФГАОУ ВО Первый Московский государственный медицинский университет имени И.М. Сеченова, Москва</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Nizhny Novgorod Science Research institute of Epidemiology and Microbiology n.a. academician I.N. Blokhina, Nizhny Novgorod</institution></aff><aff><institution xml:lang="ru">ФБУН Нижегородский НИИ эпидемиологии и микробиологии им. академика И.Н. Блохиной Роспотребнадзора, Нижний Новгород</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">St. Petersburg Pasteur Institute, St. Petersburg</institution></aff><aff><institution xml:lang="ru">ФБУН НИИ эпидемиологии и микробиологии имени Пастера, Санкт-Петербург</institution></aff></aff-alternatives><aff-alternatives id="aff4"><aff><institution xml:lang="en">Khabarovsk Research Institute of Epidemiology and Microbiology, Khabarovsk</institution></aff><aff><institution xml:lang="ru">ФБУН НИИ эпидемиологии и микробиологии, г. Хабаровск</institution></aff></aff-alternatives><aff-alternatives id="aff5"><aff><institution xml:lang="en">Federal Center of Hygiene and Epidemiology of the Inspectorate for Customers Protection of Rospotrebnadzor, Moscow</institution></aff><aff><institution xml:lang="ru">ФБУЗ Федеральный центр гигиены и эпидемиологии Роспотребнадзора, Москва</institution></aff></aff-alternatives><aff-alternatives id="aff6"><aff><institution xml:lang="en">Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Moscow</institution></aff><aff><institution xml:lang="ru">Федеральный научный центр исследований и разработки иммунобиологических препаратов им. М.П. Чумакова РАН, Москва</institution></aff></aff-alternatives><aff-alternatives id="aff7"><aff><institution xml:lang="en">Institute of Translational Medicine and Biotechnology, Sechenov First Moscow State Medical University, Moscow</institution></aff><aff><institution xml:lang="ru">Институт трансляционной медицины и биотехнологии, ФГАОУ ВО Первый Московский государственный медицинский университет имени И.М. Сеченова, Москва</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2018-12-30" publication-format="electronic"><day>30</day><month>12</month><year>2018</year></pub-date><volume>8</volume><issue>4</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>452</fpage><lpage>464</lpage><history><date date-type="received" iso-8601-date="2018-12-14"><day>14</day><month>12</month><year>2018</year></date><date date-type="accepted" iso-8601-date="2018-12-14"><day>14</day><month>12</month><year>2018</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2018, Lukashev A.N., Golitsina L.N., Vakulenko Y.A., Akhmadishina L.V., Romanenkova N.I., Sapega E.Y., Morozova N.S., Novikova N.A., Trotsenko O.E., Ivanova O.E.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2018, Лукашев А.Н., Голицына Л.Н., Вакуленко Ю.А., Ахмадишина Л.В., Романенкова Н.И., Сапега Е.Ю., Морозова Н.С., Новикова Н.А., Троценко О.Е., Иванова О.Е.</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="en">Lukashev A.N., Golitsina L.N., Vakulenko Y.A., Akhmadishina L.V., Romanenkova N.I., Sapega E.Y., Morozova N.S., Novikova N.A., Trotsenko O.E., Ivanova O.E.</copyright-holder><copyright-holder xml:lang="ru">Лукашев А.Н., Голицына Л.Н., Вакуленко Ю.А., Ахмадишина Л.В., Романенкова Н.И., Сапега Е.Ю., Морозова Н.С., Новикова Н.А., Троценко О.Е., Иванова О.Е.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://iimmun.ru/iimm/article/view/828">https://iimmun.ru/iimm/article/view/828</self-uri><abstract xml:lang="en"><p><bold>Abstract. </bold>Enteroviruses are small RNA viruses, which are ubiquitous and commonly cause outbreaks with various clinical manifestations. In 2006, the Program on enterovirus surveillance was approved in the Russian Federation. Over the last years, molecular-biological and bioinformatics methods for enterovirus epidemiology studies have been developed both in Russia and worldwide. Currently, identification of enteroviruses is carried out by analyzing nucleotide sequence of the full-length VP1 genome region (ca. 900 nt). Routinely, it is sufficient to obtain a partial VP1 genome region sequence (ca. 300 bp) for enteroviruse verification in most cases; however, a more stringent type criterion of 80% sequence identity should be used compared to the 75% sequence identity cut-off for the complete VP1 genome region. Further sequence analysis may be performed by using Bayesian phylogenetic methods, which allow using molecular clock to trace outbreak emergence. Enteroviruses accumulate about 0.5–1% nucleotide substitutions per year. Therefore, a short genome fragment may be used to analyze virus phylodynamics at the level of international transfers and circulating virus variants. On a shorter timescale, a full-length VP1 genome region or a complete genome sequence are preferred for investigating molecular epidemiology, because a short sequence allows to reliably distinguish not more than 1–2 transmission events per year. Thus, determining enterovirus sequences for full-length VP1 genome region or full-genome sequence is preferred for examining viral outbreaks. It is increasingly apparent that analyzing available enterovirus nucleotide sequences reveals limitations related to uneven surveillance efficacy in various countries and short length of genome fragment measured in routine control. As a result, a proper global-scale analysis of enterovirus molecular epidemiology remains problematic. Over the last 20 years, the number of available enterovirus nucleotide sequences increased by hundred times, but understanding emergence of enterovirus infection outbreaks remains limited. Further development of enterovirus surveillance would require new methods for sewage monitoring, affordable high-throughput sequencing and harmonization of global surveillance systems.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Резюме. </bold>Энтеровирусы — мелкие РНК-содержащие вирусы, которые распространены повсеместно и регулярно становятся причиной вспышек заболеваемости с различной симптоматикой. В Российской Федерации с 2006 г. действует надзор за энтеровирусами. За эти годы в России и в мире были отработаны молекулярно-биологические и биоинформатические инструменты для изучения эпидемиологии энтеровирусов. В настоящее время идентификация энтеровирусов в мире осуществляется практически исключительно на основании анализа нуклеотидной последовательности области генома VP1 (около 900 нуклеотидов). При этом в рутинной работе определяется только фрагмент этой области генома (около 300 нуклеотидов). В большинстве случаев этого достаточно, чтобы достоверно типировать вирус, однако точность анализа короткого участка генома ниже, и достоверным критерием типа для короткого фрагмента следует считать 80% сходства нуклеотидной последовательности, а не 75%, как в случае полной области генома VP1. Для даль нейшего анализа полученных нуклеотидных последовательностей в настоящее время широко применяются Байесовы филогенетические методики, которые позволяют использовать метод молекулярных часов в расследовании вспышек заболеваемости. Энтеровирусы накапливают порядка 0,5–1% нуклеотидных замен в год, поэтому даже короткий фрагмент генома позволяет анализировать филодинамику вирусов на уровне передачи между странами или смены циркулирующего варианта вируса. На более короткой временной шкале короткий фрагмент ограниченно пригоден для изучения молекулярной эпидемиологии, поскольку позволяет достоверно различать не более 1–2 случаев передачи вируса в год. Таким образом, для расследования вспышек желательно определение нуклеотидной последовательности полной области генома VP1 или полногеномной последовательности. В результате анализа имеющихся в базах данных нуклеотидных последовательностей энтеровирусов все более очевидными становятся ограничения, связанные с неравномерной эффективностью надзора в разных странах мира и короткой длиной фрагмента генома, определяемой при рутинном надзоре. Как следствие, полноценный анализ молекулярной эпидемиологии энтеровирусов в глобальном масштабе остается проблематичным. Количество известных нуклеотидных последовательностей энтеровирусов за последние 20 лет выросло в сотни раз, однако понимание закономерностей возникновения вспышек энтеровирусной инфекции практически отсутствует. Эффективное развитие надзора за энтеровирусами потребует внедрения новых методов исследования сточных вод, экономически эффективного высокопроизводительного секвенирования, гармонизации систем надзора в разных странах мира.</p></trans-abstract><kwd-group xml:lang="en"><kwd>enterovirus</kwd><kwd>meningitis</kwd><kwd>epidemiology</kwd><kwd>surveillance</kwd><kwd>phylogenetics</kwd><kwd>evolution</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>энтеровирус</kwd><kwd>менингит</kwd><kwd>эпидемиология</kwd><kwd>надзор</kwd><kwd>филогенетика</kwd><kwd>эволюция</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>1. Голицына Л.Н., Зверев В.В., Парфенова О.В., Новикова Н.А. Эпидемические варианты неполиомиелитных энтеровирусов в России // Медицинский альманах. 2015. Т. 40, № 5. С. 136–140. [Golitsyna L.N., Zverev V.V., Parfenova O.V., Novikova N.A. Epidemic variants of non-poliomyelitic enteroviruses in Russia. Meditsinskii al’manakh = Medical Almanac, 2015, vol. 40, no. 5, pp. 136–140. (In Russ.)]</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>2. Лашкевич В.А., Королева Г.А., Лукашев А.Н., Денисова Е.В., Катаргина Л.А., Хорошилова-Маслова И.П. Острый энтеровирусный увеит у детей младшего возраста // Вопросы вирусологии. 2005. T. 50, № 3. C. 36–45. [Lashkevich V.A., Koroleva G.A., Lukashev A.N., Denisova E.V., Katargina L.A., Khoroshilova-Maslova I.P. Acute enterovirus uveitis in young children. Voprosy virusologii = Problems of Virology, 2005, vol. 50, no. 3, pp. 36–45. (In Russ.)]</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>3. Лукашев А.Н. Роль рекомбинации в эволюции энтеровирусов // Вопросы вирусологии. 2005. T. 50, № 3. C. 46–52. [Lukashev A.N. Role of recombination in evolution of enteroviruses. Voprosy virusologii = Problems of Virology, 2005, vol. 50, no. 3, pp. 46–52. (In Russ.)]</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>4. Лукашев А.Н., Резник В.И., Иванова О.Е., Еремеева Т.П., Каравянская Т.Н., Перескокова М.А., Лебедева Л.А., Лашкевич В.А., Михайлов М.И. Молекулярная эпидемиология вируса ЕСНО 6 — возбудителя вспышки серозного менингита в Хабаровске в 2006 г. // Вопросы вирусологии. 2008. Т. 53, № 1. C. 16–21. [Lukashev A.N., Reznik V.I., Ivanova O.E., Eremeyeva T.P., Karavyanskaya T.N., Pereskokova M.A., Lebedeva L.A., Lashkevich V.A., Mikhallov M.I. Molecular epidemiolo gy of ECHO 6 virus, the causative agent of the 2006 outbreak of serous meningitis in Khabarovsk. Voprosy virusologii = Problems of Virology, 2008, vol. 53, no. 1, pp. 16–21. (In Russ.)]</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>5. Устюжанин А.В., Резайкин А.В., Сергеев А.Г., Снитковская Т.Э. Значение молекулярно-генетического мониторинга в оценке степени вирулентности и эпидемической значимости штаммов неполиомиелитных энтеровирусов, циркулирующих среди населения // Вестник Уральской медицинской академической науки. 2015. Т. 52, № 1. С. 72–76. [Ustyuzhanin A.V., Rezaykin A.V., Sergeev A.G., Snitkovskaya T.E. Molecular genetic surveillance of circulating human nonpoliomyelitis viruses strains: implications for the estimates of epidemic significance and virulence. Vestnik Ural’skoi meditsinskoi akademicheskoi nauki = Journal of Ural Medical Academic Science, 2015, vol. 52, no. 1, pp. 72–76. (In Russ.)]</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>6. Akhmadishina L.V., Govorukhina M.V., Kovalev E.V., Nenadskaya S.A., Ivanova O.E., Lukashev A.N. Enterovirus A71 meningoencephalitis outbreak, Rostov-on-Don, Russia, 2013. Emerg. Infect. Dis., 2015, vol. 21, no. 8, pp. 1440–1443. doi: 10.3201/eid2108.141084</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>7. Bailly J.L., Mirand A., Henquell C., Archimbaud C., Chambon M., Charbonne F., Traore O., Peigue-Lafeuille H. Phylogeography of circulating populations of human echovirus 30 over 50 years: nucleotide polymorphism and signature of purifying selection in the VP1 capsid protein gene. Infect. Genet. Evol., 2009, vol. 9, no. 4, pp. 699–708. doi: 10.1016/j.meegid.2008.04.009</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>8. Brown B.A., Maher K., Flemister M.R., Naraghi-Arani P., Uddin M., Oberste M.S., Pallansch M.A. Resolving ambiguities in genetic typing of human enterovirus species C clinical isolates and identification of enterovirus 96, 99 and 102. J. Gen. Virol., 2009, vol. 90, no. 7, pp. 1713–1723. doi: 10.1099/vir.0.008540-0</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>9. Centers for Disease Control and Prevention. Certification of poliomyelitis eradication — European Region, June 2002. MMWR Morb. Mortal. Wkly Rep., 2002, vol. 51, no. 26, pp. 572–574.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>10. Chumakov K.M., Powers L.B., Noonan K.E., Roninson I.B., Levenbook I.S. Correlation between amount of virus with altered nucleotide sequence and the monkey test for acceptability of oral poliovirus vaccine. Proc. Natl. Acad. Sci. USA, 1991, vol. 88, no. 1, pp. 199–203.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>11. Drummond A.J., Rambaut A. BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol. Biol., 2007, vol. 7, pp. 214. doi: 10.1186/1471-2148-7-214</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>12. Gaunt E., Harvala H., Osterback R., Sreenu V.B., Thomson E., Waris M., Simmonds P. Genetic characterization of human coxsackievirus A6 variants associated with atypical hand, foot and mouth disease: a potential role of recombination in emergence and pathogenicity. J. Gen. Virol., 2015, vol. 96, no. 5, pp. 1067–1079. doi: 10.1099/vir.0.000062</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>13. Hassel C., Mirand A., Lukashev A., Terletskaialadwig E., Farkas A., Schuffenecker I., Diedrich S., Huemer H.P., Archimbaud C., Peigue-Lafeuille H., Henquell C., Bailly J.L. Transmission patterns of human enterovirus 71 to, from and among European countries, 2003 to 2013. Euro Surveill., 2015, vol. 20, no. 34. doi: 10.2807/1560-7917.ES.2015.20.34.30005</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>14. Ho M., Chen E.R., Hsu K.H., Twu S.J., Chen K.T., Tsai S.F., Wang J.R., Shih S.R. An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N. Engl. J. Med., 1999, vol. 341, no. 13, pp. 929–935. doi: 10.1056/NEJM199909233411301</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>15. Khetsuriani N., Lamonte-Fowlkes A., Oberste S., Pallansch M.A. Enterovirus surveillance — United States, 1970–2005. MMWR Surveill. Summ., 2006, vol. 55, no. 8, pp. 1–20.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>16. Lancaster K.Z., Pfeiffer J.K. Mechanisms controlling virulence thresholds of mixed viral populations. J. Virol., 2011, vol. 85, no. 19, pp. 9778–9788. doi: 10.1128/JVI.00355-11</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>17. Lemey P., Rambaut A., Welch J.J., Suchard M.A. Phylogeography takes a relaxed random walk in continuous space and time. Mol. Biol. Evol., 2010, vol. 27, no. 8, pp. 1877–1885. doi: 10.1093/molbev/msq067</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>18. Liste M.B., Natera I., Suarez J.A., Pujol F.H., Liprandi F., Ludert J.E. Enteric virus infections and diarrhea in healthy and human immunodeficiency virus-infected children. J. Clin. Microbiol., 2000, vol. 38, no. 8, pp. 2873–2877.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>19. Liu W., Wu S., Xiong Y., Li T., Wen Z., Yan M., Qin K., Liu Y., Wu J. Co-circulation and genomic recombination of coxsackievirus A16 and enterovirus 71 during a large outbreak of hand, foot, and mouth disease in Central China. PLoS One, 2014, vol. 9, no. 4: e96051. doi: 10.1371/journal.pone.0096051</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>20. Lukashev A.N., Lashkevich V.A., Ivanova O.E., Koroleva G.A., Hinkkanen A.E., Ilonen J. Recombination in circulating enteroviruses. J. Virol., 2003, vol. 77, no. 19, pp. 10423–10431. doi: 10.1128/JVI.77.19.10423-10431.2003</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>21. Lukashev A.N., Lashkevich V.A., Ivanova O.E., Koroleva G.A., Hinkkanen A.E., Ilonen J. Recombination in circulating enterovirus B: independent evolution of structural and non-structural genome regions. J. Gen. Virol., 2005, vol. 86, no. 12, pp. 3281– 3290. doi: 10.1099/vir.0.81264-0</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>22. Lukashev A.N., Vakulenko Y.A. Molecular evolution of types in non-polio enteroviruses. J. Gen. Virol., 2017, vol. 98, no. 12, pp. 2968–2981. doi: 10.1099/jgv.0.000966</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>23. McMinn P.C. Recent advances in the molecular epidemiology and control of human enterovirus 71 infection. Curr. Opin. Virol., 2012, vol. 2, no. 2, pp. 199–205. doi: 10.1016/j.coviro.2012.02.009</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>24. McWilliam Leitch E.C., Bendig J., Cabrerizo M., Cardosa J., Hyypia T., Ivanova O.E., Kelly A., Kroes A.C., Lukashev A., MacAdam A., McMinn P., Roivainen M., Trallero G., Evans D.J., Simmonds P. Transmission networks and population turnover of echovirus 30. J. Virol., 2009, vol. 83, no. 5, pp. 2109–2118. doi: 10.1128/JVI.02109-08</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>25. McWilliam Leitch E.C., Cabrerizo M., Cardosa J., Harvala H., Ivanova O.E., Koike S., Kroes A.C., Lukashev A., Perera D., Roivainen M., Susi P., Trallero G., Evans D.J., Simmonds P. The association of recombination events in the founding and emergence of subgenogroup evolutionary lineages of human enterovirus 71. J. Virol., 2012, vol. 86, no. 5, pp. 2676–2685. doi: 10.1128/JVI.06065-11</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>26. McWilliam Leitch E.C., Cabrerizo M., Cardosa J., Harvala H., Ivanova O.E., Kroes A.C., Lukashev A., Muir P., Odoom J., Roivainen M., Susi P., Trallero G., Evans D.J., Simmonds P. Evolutionary dynamics and temporal/geographical correlates of recombination in the human enterovirus echovirus types 9, 11, and 30. J. Virol., 2010, vol. 84, no. 18, pp. 9292–9300. doi: 10.1128/JVI.00783-10</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>27. Nasri D., Bouslama L., Omar S., Saoudin H., Bourlet T., Aouni M., Pozzetto B., Pillet S. Typing of human enterovirus by partial sequencing of VP2. J. Clin. Microbiol., 2007, vol. 45, no. 8, pp. 2370–2379. doi: 10.1128/JCM.00093-07</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>28. Nomoto A. Molecular aspects of poliovirus pathogenesis. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci., 2007, vol. 83, no. 8, pp. 266–275. doi: 10.2183/pjab/83.266</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>29. Oberste M.S., Maher K., Kilpatrick D. R., Flemister M.R., Brown B.A., Pallansch M.A. Typing of human enteroviruses by partial sequencing of VP1. J. Clin. Microbiol., 1999, vol. 37, pp. 1288–1293.</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>30. Oberste M.S., Maher K., Kilpatrick D.R., Pallansch M.A. Molecular evolution of the Human enteroviruses: correlation of serotype with VP1 sequence and application to picornavirus classification. J. Virol., 1999, vol. 73, pp. 1941–1948.</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>31. Oberste M.S., Nix W.A., Kilpatrick D.R., Flemister M.R., Pallansch M.A. Molecular epidemiology and type-specific detection of echovirus 11 isolates from the Americas, Europe, Africa, Australia, southern Asia and the Middle East. Virus Res., 2003, vol. 91, pp. 241–248. doi: 10.1016/S0168-1702(02)00291-5</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>32. Palacios G., Oberste M.S. Enteroviruses as agents of emerging infectious diseases. J. Neurovirol., 2005, vol. 11, no. 5, pp. 424–433. doi: 10.1080/13550280591002531</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>33. Puenpa J., Vongpunsawad S., Osterback R., Waris M., Eriksson E., Albert J., Midgley S., Fischer T.K., Eis-Hubinger A.M., Cabrerizo M., Gaunt E., Simmonds P., Poovorawan Y. Molecular epidemiology and the evolution of human coxsackievirus A6. J. Gen. Virol., 2016, vol. 97, no. 12, pp. 3225–3231. doi: 10.1099/jgv.0.000619</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>34. Savolainen-Kopra C., Paananen A., Blomqvist S., Klemola P., Simonen M.L., Lappalainen M., Vuorinen T., Kuusi M., Lemey P., Roivainen M. A large Finnish echovirus 30 outbreak was preceded by silent circulation of the same genotype. Virus Genes, 2011, vol. 42, no. 1, pp. 28–36. doi: 10.1007/s11262-010-0536-x</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>35. Simonen-Tikka M.L., Hiekka A.K., Klemola P., Poussa T., Ludvigsson J., Korpela R., Vaarala O., Roivainen M. Early human enterovirus infections in healthy Swedish children participating in the PRODIA pilot study. J. Med. Virol., 2012, vol. 84, no. 6, pp. 923–930. doi: 10.1002/jmv.23284</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>36. Solmone M., Vincenti D., Prosperi M.C., Bruselles A., Ippolito G., Capobianchi M.R. Use of massively parallel ultradeep pyrosequencing to characterize the genetic diversity of hepatitis B virus in drug-resistant and drug-naive patients and to detect minor variants in reverse transcriptase and hepatitis B S antigen. J. Virol., 2009, vol. 83, no. 4, pp. 1718–1726. doi: 10.1128/JVI.02011-08</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>37. Tamura K., Stecher G., Peterson D., Filipski A., Kumar S. MEGA6: Molecular Evolutionary Genetics Analysis version 6.0. Mol. Biol. Evol., 2013, vol. 30, no. 12, pp. 2725–2729. doi: 10.1093/molbev/mst197</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>38. Van der Sanden S.M., Koopmans M.P., van der Avoort H.G. Detection of human enteroviruses and parechoviruses as part of the national enterovirus surveillance in the Netherlands, 1996-2011. Eur. J. Clin. Microbiol. Infect. Dis., 2013, vol. 32, no. 12, pp. 1525– 1531. doi: 10.1007/s10096-013-1906-9</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>39. Witso E., Palacios G., Cinek O., Stene L.C., Grinde B., Janowitz D., Lipkin W.I., Ronningen K.S. High prevalence of human enterovirus a infections in natural circulation of human enteroviruses. J. Clin. Microbiol., 2006, vol. 44, no. 11, pp. 4095–4100. doi: 10.1128/JCM.00653-06</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>40. Wright P.W., Strauss G.H., Langford M.P. Acute hemorrhagic conjunctivitis. Am. Fam. Physician, 1992, vol. 45, no. 1, pp. 173–178.</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>41. Yakovenko M.L., Gmyl A.P., Ivanova O.E., Eremeeva T.P., Ivanov A.P., Prostova M.A., Baykova O.Y., Isaeva O.V., Lipskaya G.Y., Shakaryan A.K., Kew O.M., Deshpande J.M., Agol V.I. The 2010 outbreak of poliomyelitis in Tajikistan: epidemiology and lessons learnt. Euro Surveill., 2014, vol. 19, no. 7, pp. 20706.</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>42. Yarmolskaya M.S., Shumilina E.Y., Ivanova O.E., Drexler J.F., Lukashev A.N. Molecular epidemiology of echoviruses 11 and 30 in Russia: different properties of genotypes within an enterovirus serotype. Infect. Genet. Evol., 2015, vol. 30, pp. 244–248. doi: 10.1016/j.meegid.2014.12.033</mixed-citation></ref></ref-list></back></article>
